期刊文献+

中药制剂生产工艺设计空间的建立 被引量:39

Establishment of design space for production process of traditional Chinese medicine preparation
原文传递
导出
摘要 质量源于设计(quality by design,QbD)的理念正推动着药品生产模式的转变,即从传统的以检验为主的制药过程到以科学和风险为基础并经过详细研究和理解的生产过程。随着对工艺的认识和理解不断深入,"设计空间"将被确定,质量控制从质量标准转移到设计空间。因此,设计空间的建立是实施QbD的核心步骤,研究设计空间的构建方法具有重要的意义。该文提出在中药制剂生产工艺中建立设计空间的设想,系统介绍了设计空间的概念,分析了在中药制剂生产工艺中构建设计空间的可行性和意义,结合实例提出符合中药制剂特点的设计空间研究方法,以及未来的研究方向。 The philosophy of quality by design (QbD) is now leading the changes in the drug manufacturing mode from the conventional testbased approach to the science and risk based approach focusing on the detailed research and understanding of the pro duction process. Along with the constant deepening of the understanding of the manufacturing process, the design space will be deter mined, and the emphasis of quality control will be shifted from the quality standards to the design space. Therefore, the establishment of the design space is core step in the implementation of QbD, and it is of great importance to study the methods for building the design space. This essay proposes the concept of design space for the production process of traditional Chinese medicine (TCM) preparations, gives a systematic introduction of the concept of the design space, analyzes the feasibility and significance to build the design space in the production process of traditional Chinese medicine preparations, and proposes study approaches on the basis of examples that com ply with the characteristics of traditional Chinese medicine preparations, as well as future study orientations.
出处 《中国中药杂志》 CAS CSCD 北大核心 2013年第6期924-929,共6页 China Journal of Chinese Materia Medica
基金 国家"重大新药创制"科技重大专项(2010ZX09502-002)
关键词 设计空间 中药制剂 生产工艺 质量源于设计 关键性 控制策略 design space traditional Chinese medicine preparation production process quality by design (QbD) criticali-ty control strategy
  • 相关文献

参考文献31

  • 1史新元,张燕玲,王耘,乔延江.中药生产过程中质量控制的思考[J].世界科学技术-中医药现代化,2008,10(5):121-125. 被引量:21
  • 2I-Iuang H S, Xie Q S, Li S B. An operation mode of manufactur- ing system for traditional Chinese medicine based on equipment integration [ C ]. Beijing : Second pacific-Asia conference on cir- cuits, communications and system (PACCS), 2010, 2: 165.
  • 3Xu B, Wu Z S, Lin Z Z, et al. NIR analysis for batch process of ethanol precipitation coupled with a new calibration model upda- ting strategy[J]. Anal Chim Acta, 2012, 720: 22.
  • 4Wu Z S, Xu B, Du M, et al. Validation of a NIR quantification method for the determination of chlorogenic acid in Lonicera japonica solution in ethanol precipitation process [ J ]. J Pharmaceut Biomed Anal, 2012, 62: 1.
  • 5U.S. Food and Drug Administration (FDA) cGMPS for the 21st century[ EB/OL]. 2002-2-20 fda. gov/Drugs/Dev Pharmaceutical http ://www. Manufacturing/ QuestionsandAnswersonCurrent Good Manufacturing PracticescGMP for Drugs/UCM071836.
  • 6U.S. Food and Drug Administration(FDA). Guidance for indus- try PAT (2004) [ EB/OLI. 2004-9-6. http://www, fda. gov! downloads/Drugs/.../Guidances/ucm070305, pdf.
  • 7Baber N. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) [J]. Br J Clin Pharmacol, 1994, 37(5): 401.
  • 8Berridge J C. PQLI: current status and future plans [ J ]. J Pharm Innov, 2009, 4( 1 ) : 1.
  • 9Gelsey A, Schwabacher M, Smith D. Using modeling knowledge to guide design space search [ J 1. Artificial Intelligence, 1998, 101(1/2) : 35.
  • 10Giles M. Methods for evaluating and covering the design space dur- ing early design development[J]. Integration, 2004, 38(2) : 131.

二级参考文献83

共引文献1091

同被引文献462

引证文献39

二级引证文献305

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部